PharmGKB Blog
Thursday, January 28, 2016

January SNPits Summary

›
The January issue of SNPits, the University of Florida’s Personalized Medicine Program e-newsletter, summarizes pharmacogenetics studies. ...
Tuesday, January 19, 2016

The Pharmacogenetic Phenome Compendium, A Chemical–Genetic Interaction Map

›
Development of new drugs is a complicated and difficult process, with many initially promising compounds falling by the wayside due to unfor...
Thursday, January 14, 2016

Constellation: tool for automated CYP2D6 phenotype assignment from WGS

›
A team  from Children’s Mercy  and the University of Missouri  in Kanas City  including Andrea Gaedigk and Greyson Twist  published an arti...
Wednesday, January 13, 2016

Cisplatin FDA label changes

›
In 2013 we blogged about the controversy with the FDA labeling for cisplatin and its warning for TPMT variants and increased risk ...
Sunday, December 20, 2015

ACMG Issues a Revised Position Statement Regarding DTC Genetic Testing

›
The American College of Medical Genetics (ACMG) recently revised its position statement regarding direct-to-consumer (DTC) genetic testing. ...
Thursday, December 17, 2015

DIGITizE Suggests Implementing 2 CPIC Guidelines in CDS

›
The DIGITizE Action Collaborative has suggested that Clinical Decision Support (CDS) be implemented based on CPIC's TPMT/azathioprine an...
Friday, December 11, 2015

Combining large PGx datasets from cancer cell lines

›
Testing cancer cell lines in vitro for drug sensitivity is a cornerstone of preclinical drug development. Large publically availab...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.